Overview


According to FutureWise analysis, the market for Anal Fistula Treatment is expected to grow at a CAGR of 4.20% over the forecast period of 2023-2031.

The Anal Fistula Treatment Market refers to the global healthcare sector that encompasses various medical treatments, procedures, and therapies aimed at diagnosing and managing anal fistulas. Anal fistulas are abnormal tunnels or passages that develop between the anal canal or rectum and the skin surrounding the anus. These conditions often result from infections or abscesses in the anal region and require medical intervention to alleviate symptoms, promote healing, and prevent complications. 

The Anal Fistula Treatment Market addresses the growing prevalence of anal fistulas, offering a range of treatment options designed to provide relief to affected individuals. Key components of this market include surgical procedures, minimally invasive techniques, and pharmaceutical interventions. The choice of treatment depends on the complexity of the fistula, patient-specific factors, and the preferences of healthcare providers. The market is driven by factors such as an increasing incidence of conditions that lead to anal fistulas, advancements in treatment modalities, and the demand for safer and more effective therapeutic options with fewer side effects and a lower chance of recurrence. Additionally, research and clinical studies contribute to the development of innovative treatments.

FutureWise Market Research has published a report that provides an insightful analysis of Anal Fistula Treatment Market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry.

According to the analysis conducted by FutureWise research analysts, the Anal Fistula Treatment Market is estimated to register a considerable growth rate over the forecast period. This report lists the market segments and potential prospects available across this industry, in addition providing crucial information on the total valuation currently held by the industry. Moreover, this report will assist key management individuals in an organisation to enhance their decisions pertaining to business expansion as well as strategic changes for increasing customer base.

  • Becton, Dickinson and Company
  • biolitec A.G.
  • Cook Medical
  • Gem srl.
  • KARL STORZ SECo., KG.
  • Medtronic plc.
  • TiGenix N.V.

(Note: The list of the major players will be updated with the latest market scenario and trends)

The Anal Fistula Treatment Market is poised for rapid growth, driven by several key factors. One of the primary drivers is the increasing incidence of inflammatory bowel diseases like Crohn's disease and ulcerative colitis. These conditions often lead to anal fistulas, necessitating treatment. Additionally, the launch of new products and the growing preference for non-surgical methods, such as fibrin glue injection and adipose-derived stem cells therapy, are contributing to market expansion. For instance, recent research funded by Crohn’s & Colitis UK and Coeliac UK in 2022 revealed a higher prevalence of Crohn’s and Colitis in the United Kingdom (UK) population than previously estimated. This study reported that 1 in every 123 people in the UK has either Crohn’s disease or ulcerative colitis, affecting nearly half a million people in the UK. This underscores the significant impact of inflammatory bowel disease on a substantial portion of the population, driving the demand for anal fistula treatment. Moreover, the rising demand for safe and effective treatments with minimal chances of recurrence and fewer side effects is prompting key industry players to introduce advanced drugs and devices. Technological advancements in anal fistula treatment, such as combined drainage Seton procedures and LIFT-plug therapy, are also propelling market growth. These advancements offer more effective and less invasive treatment options for complex anal fistulas thus further propelling market growth. However, the high cost associated with treatment and a lack of awareness among patients and healthcare providers regarding available treatment options are expected to hinder market growth.

By Treatment Type

  • Non-surgical
    • Drugs
    • Others (fibrin glue, adipose stem cell therapy, etc.)
  • Surgical
    • Fistulotomy
    • Bioprosthetic Plugs
    • Advancement Flap Procedures
    • Seton Techniques
    • Others

By Application

  • Intersphincteric
  • Transsphincteric
  • Suprasphincteric
  • Extrasphincteric
  • Others

By End-user

  • Hospitals and Ambulatory Surgical Centers
  • Clinics
  • Others

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

This market research report also emphasis on factors affecting the growth rate in various regions listed above. A deep-down analysis of region will also be provided in the final version of this market which is based on conclusion of primary interviews and secondary data point gathered during the process.

By region, the market is segmented into North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa. North America registered highest share in the market in 2022. A substantial patient population in the region, particularly those affected by inflammatory bowel diseases, such as Crohn's disease and ulcerative colitis, contributes significantly to the market's prominence. This high prevalence of related conditions necessitates the management of anal fistulas, bolstering demand for treatment options. Moreover, North America showcases early adoption of cutting-edge technologies and boasts significant healthcare expenditure from both public and private sectors. This financial commitment to healthcare enables the region to stay at the forefront of medical advancements, including those related to anal fistula treatment. Furthermore, North America's commitment to advancing anal fistula treatment is evidenced by collaborations and clinical trials conducted by healthcare organizations and research institutions. The partnership between California-based Ossium Health and Cleveland Clinic for a clinical trial focusing on mesenchymal stem cell therapy for pouch fistulas in Crohn's disease patients demonstrates the region's dedication to innovative approaches. This study aims to explore the safety and feasibility of using vertebral Bone Marrow-Derived Mesenchymal Stem Cells (vBM-MSC) to address pouch fistulas, showcasing the region's contribution to advancing treatment modalities.

 

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the Anal Fistula Treatment Market By Treatment Type, By Application, By End-user and By Region.
  • To cater comprehensive insights on factors such as drivers, restraints, trends, opportunity, and additionally segmental and regional factors impacting market growth.
  • To evaluate current market trends and forecast micro-markets and the overall market projections which are represented in the format of data-sets and ppt.
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa. 
  • To provide information on competitors which includes landscape mapping, technological advancements, R&D spending, news concerning strategic alliances, and new product launches

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

 

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Anal Fistula Treatment Market Variables, Trends and Scope

    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Anal Fistula Treatment Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Anal Fistula Treatment Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Anal Fistula Treatment Market, By Treatment Type Historical Analysis and Forecast 2023-2031 (USD Million)

    •   1. Non-surgical
         1.1. Drugs
         1.2. Others (fibrin glue, adipose stem cell therapy, etc.)
        2. Surgical
         2.1. Fistulotomy
         2.2. Bioprosthetic Plugs
         2.3. Advancement Flap Procedures
         2.4. Seton Techniques
         2.5. Others

  • 8.   Anal Fistula Treatment Market, By Application Historical Analysis and Forecast 2023-2031 (USD Million)

    •   1. Intersphincteric
        2. Transsphincteric
        3. Suprasphincteric
        4. Extrasphincteric
        5. Others

  • 9.   Anal Fistula Treatment Market, By End-user Historical Analysis and Forecast 2023-2031 (USD Million)

    •   1. Hospitals and Ambulatory Surgical Centers
        2. Clinics
        3. Others

  • 10.   North America Anal Fistula Treatment Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 11.   Latin America Anal Fistula Treatment Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 12.   Europe Anal Fistula Treatment Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 13.   Asia Pacific Anal Fistula Treatment Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 14.   Middle East and Africa Anal Fistula Treatment Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 15.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 16.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)

    •   1. Becton, Dickinson and Company
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. biolitec A.G.
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Cook Medical
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Gem srl.
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. KARL STORZ SECo., KG.
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Medtronic plc.
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. TiGenix N.V.
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview

  • 17.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the regulations initiated by healthcare administrations
        5. The overall economic slowdown of the developing and developed nations
  • 18.   FutureWise SME Key Takeaway Points for Client

Ask for Discount
Buy Now
Customize This Report
  • We Offer Special Discounts for start-ups, NGOs, and Educational & Research institutions.

Need Assistance

  • UK : +44 141 628 9353
  • US : +1 347 709 4931

Related Market

Anal Fissure Treatment Market

Read More

What you get

  • Excel Dataset
  • Market Overview
  • Infographics
  • PowerPoint Presentation
  • PDF Report

What's included

  • Consumer Perception and Procurement
  • Market Data Forecast
  • Competitive Analysis
  • Risks and Opportunity Assessment
  • Market Trends and Dynamics
Partner

Our Clients

image0
image1
image2
image3
image4
image5
image6
image7
image8
image9
image10
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11